Claudio Laudani on Dual Versus Single Antiplatelet Therapy
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Dual antiplatelet therapy (DAPT) has long been the cornerstone of treatment after PCI, but advances in stent technology and pharmacology are reshaping how we balance ischemic protection and bleeding risk.
In this comprehensive review, we examine:
- The pharmacodynamic rationale of DAPT versus single antiplatelet therapy (SAPT), including differences among P2Y12 inhibitors.
- Clinical evidence comparing DAPT and SAPT strategies in chronic coronary syndrome and acute coronary syndrome patients undergoing PCI.
- The evolving role of early DAPT de-escalation and P2Y12 inhibitor monotherapy in optimizing net clinical benefit.
- Practical considerations for tailoring antiplatelet therapy based on individual ischemic and bleeding risk profiles, and areas where evidence remains limited.
Read more in our review article.”
Article: The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapy
Authors: Claudio Laudani, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Ali Zgheib, Georges El Khoury, Maryam Farahmandsadr, Mohmmad Alawajneh, Marco Spagnolo, Giovanni Occhipinti, Davide Capodanno, Dominick J. Angiolillo
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin
-
Jan 12, 2026, 15:07Aaron Iding and Colleagues on Additional Oxerutin Link to DVT